OTC Pharmaceuticals in South Korea

Product Code DAT02669
Publication Date November 2010
Publisher Datamonitor
Product Type Report
Pages 41
ISBN Number not applicable

OTC Pharmaceuticals in South Korea

Datamonitor's OTC Pharmaceuticals in South Korea industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

  • Contains an executive summary and data on value, volume and/or segmentation
  • Provides textual analysis of OTC Pharmaceuticals in South Korea's recent performance and future prospects
  • Incorporates in-depth five forces competitive environment analysis and scorecards
  • Includes a five-year forecast of OTC Pharmaceuticals in South Korea
  • The leading companies are profiled with supporting key financial metrics
  • Supported by the key macroeconomic and demographic data affecting the market

Highlights

  • Detailed information is included on market size, measured by both value and volume
  • Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
  • Market shares are covered by manufacturer and/or brand
  • Also features market breakdown by distribution channel

Why you should buy this report

  • Spot future trends and developments
  • Inform your business decisions
  • Add weight to presentations and marketing materials
  • Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria's, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness).

For the purposes of this report, Asia-Pacific comprises Australia, China, India, Japan, Singapore, South Korea, and Taiwan.

Contents

  • Executive Summary
  • Market Overview
    • Market Definition
    • Research Highlights
    • Market Analysis
  • Market Value
  • Market Segmentation I
  • Market Segmentation II
  • Market Share
  • Five Forces Analysis
    • Summary
    • Buyer Power
    • Supplier Power
    • New Entrants
    • Substitutes
    • Rivalry
  • Leading Companies
    • Dong Wha Pharmaceutical Industrial Co. Ltd
    • Johnson & Johnson
    • Whanin Pharmaceuticals Co. Ltd
  • Market Distribution
  • Market Forecasts
    • Market Value Forecast
  • Macroeconomic Indicators
  • Appendix
    • Methodology
    • Industry Associations
    • Related Datamonitor Research
    • Disclaimer
  • About Datamonitor
    • Premium Reports
    • Summary Reports
    • Datamonitor Consulting
  • List of Tables
    • Table 1: South Korea Otc Pharmaceuticals Market Value: $ Million, 2005-09
    • Table 2: South Korea Otc Pharmaceuticals Market Segmentation I:% Share, by Value, 2009
    • Table 3: South Korea Otc Pharmaceuticals Market Segmentation II: % Share, by Value, 2009
    • Table 4: South Korea Otc Pharmaceuticals Market Share: % Share, by Value, 2009
    • Table 5: Dong Wha Pharmaceutical Industrial Co. Ltd.: Key Facts
    • Table 6: Johnson & Johnson: Key Facts
    • Table 7: Johnson & Johnson: Key Financials ($)
    • Table 8: Johnson & Johnson: Key Financial Ratios
    • Table 9: Whanin Pharmaceuticals Co. Ltd.: Key Facts
    • Table 10: Whanin Pharmaceuticals Co. Ltd.: Key Financials ($)
    • Table 11: Whanin Pharmaceuticals Co. Ltd.: Key Financials (Krw)
    • Table 12: Whanin Pharmaceuticals Co. Ltd.: Key Financial Ratios
    • Table 13: South Korea Otc Pharmaceuticals Market Distribution: % Share, by Value, 2009
    • Table 14: South Korea Otc Pharmaceuticals Market Value Forecast: $ Million, 2009-14
    • Table 15: South Korea Size of Population (Million), 2005-09
    • Table 16: South Korea Gdp (Constant 2000 Prices, $ Billion), 2005-09
    • Table 17: South Korea Gdp (Current Prices, $ Billion), 2005-09
    • Table 18: South Korea Inflation, 2005-09
    • Table 19: South Korea Consumer Price Index (Absolute), 2005-09
    • Table 20: South Korea Exchange Rate, 2005-09
  • List of Figures
    • Figure 1: South Korea Otc Pharmaceuticals Market Value: $ Million, 2005-09
    • Figure 2: South Korea Otc Pharmaceuticals Market Segmentation I:% Share, by Value, 2009
    • Figure 3: South Korea Otc Pharmaceuticals Market Segmentation II: % Share, by Value, 2009
    • Figure 4: South Korea Otc Pharmaceuticals Market Share: % Share, by Value, 2009
    • Figure 5: Forces Driving Competition in The Otc Pharmaceuticals Market in South Korea, 2009
    • Figure 6: Drivers of Buyer Power in The Otc Pharmaceuticals Market in South Korea, 2009
    • Figure 7: Drivers of Supplier Power in The Otc Pharmaceuticals Market in South Korea, 2009
    • Figure 8: Factors Influencing The Likelihood of New Entrants in The Otc Pharmaceuticals Market in South Korea, 2009
    • Figure 9: Factors Influencing The Threat of Substitutes in The Otc Pharmaceuticals Market in South Korea, 2009
    • Figure 10: Drivers of Degree of Rivalry in The Otc Pharmaceuticals Market in South Korea, 2009
    • Figure 11: Johnson & Johnson: Revenues & Profitability
    • Figure 12: Johnson & Johnson: Assets & Liabilities
    • Figure 13: Whanin Pharmaceuticals Co. Ltd.: Revenues & Profitability
    • Figure 14: Whanin Pharmaceuticals Co. Ltd.: Assets & Liabilities
    • Figure 15: South Korea Otc Pharmaceuticals Market Distribution: % Share, by Value, 2009
    • Figure 16: South Korea Otc Pharmaceuticals Market Value Forecast: $ Million, 2009-14